Sebastian Schneeweiss is Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics of the Department of Medicine, Brigham and Women’s Hospital, a world-leading research and training center.
His research is funded by multiple NIH, PCORI, BWF, and FDA grants and focuses on the comparative effectiveness and safety of biopharmaceuticals. He has developed analytic methods to improve the scientific validity of epidemiologic analyses using complex longitudinal healthcare databases particularly for newly marketed medical products. Applying such methods in rapid analysis cycles for sequential medication effectiveness monitoring and rapid response analyses is the overarching theme of his research. He is Aetion Inc.’s co-founder and Science Advisor were he develops a range of rapid-cycle analytics platforms for healthcare database networks around the world.
Dr. Schneeweiss is PI of the Sentinel Innovation Center funded by FDA/CDER were he is a voting consultant to the FDA Drug Safety and Risk Management Advisory Committee. He was an inaugural member of the Methods Committee of the Patient-Centered Outcomes Research Institute. He is Past President of the International Society for Pharmacoepidemiology and is Fellow of the American College of Epidemiology, the American College of Clinical Pharmacology, and the International Society for Pharmacoepidemiology.
At Harvard he teaches courses on Database Analytics for Pharmacoepidemiology (EPI286) and on Effectiveness Research in Longitudinal Healthcare Databases (EPI253), Medications and Evidence (AISC604) among others.
He received his medical training at the University of Munich Medical School and his doctoral degree from Harvard.
Hansford HJ, Cashin AG, Jones MD, Swanson SA, Islam N, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne J, Sharp MK, Stuart EA, Hernan MA, Lee H, McAuley JH.
BMJ Open. 2023 Sep 12. 13(9):e074626. PMID: 37699620
Kutz A, Kim DH, Wexler DJ, Liu J, Schneeweiss S, Glynn RJ, Patorno E.
Diabetes Care. 2023 Sep 07. PMID: 37677118
Hansford HJ, Cashin AG, Jones MD, Swanson SA, Islam N, Douglas SRG, Rizzo RRN, Devonshire JJ, Williams SA, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne JAC, Sharp MK, Stuart EA, Hernán MA, Lee H, McAuley JH.
JAMA Netw Open. 2023 Sep 05. 6(9):e2336023. PMID: 37755828
Schneeweiss S, Schneeweiss M.
JID Innov. 2023 Nov. 3(6):100226. PMID: 37744690
Wang SV, Schneeweiss S.
JAMA. 2023 Aug 22. 330(8):770-771. PMID: 37606676
Schneeweiss MC.
J Am Acad Dermatol. 2023 Aug 19. PMID: 37604229
Heyard R, Held L, Schneeweiss S, Wang SV.
medRxiv. 2023 Jul 13. PMID: 37502999
DeMichele A, Robert N, Chen C, Kim S, Zhang Z, Lu DR, Aguilar KM, Wang Y, Li B, Schneeweiss S, Rassen JA, Gaffney M, McRoy L.
Target Oncol. 2023 Jul. 18(4):543-558. PMID: 37428347
Shin H, Wang SV, Kim DH, Alt E, Mahesri M, Bessette LG, Schneeweiss S, Najafzadeh M.
Clin Pharmacol Ther. 2023 Jun 26. PMID: 37365904
Fu EL, Patorno E, Everett BM, Vaduganathan M, Solomon SD, Levin R, Schneeweiss S, Desai RJ.
Eur Heart J. 2023 06 25. 44(24):2216-2230. PMID: 37259575